MICROCALORIMETRIC STUDY FOR THE BINDING OF IONIC DRUGS TO HUMAN ERYTHROCYTES AND THE GHOST MEMBRANES

被引:18
作者
AKI, H [1 ]
YAMAMOTO, M [1 ]
机构
[1] FUKUOKA UNIV,FAC PHARMACEUT SCI,DEPT PHARMACEUT,8-19-1 NANAKUMA,JONAN KU,FUKUOKA 81401,JAPAN
关键词
D O I
10.1111/j.2042-7158.1990.tb06622.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abstract— The binding of phenothiazine derivatives (as cationic drugs) and non‐steroidal anti‐inflammatory drugs (as anionic drugs) to human erythrocytes and ghost membranes has been compared with respect to their thermodynamic characteristics, by flow microcalorimetry at pH 7.4 and 37°C. From enthalpy‐entropy correlation, it was shown that anionic and cationic drugs are bound to different binding sites on the membranes. Phenothiazines bind to a single common site of the erythrocyte membranes with relatively high binding affinities (K = 104‐105 M−1). The binding is entropy‐driven and characterized by a small negative enthalpy (ΔH) and a positive entropy change (ΔS), reflecting hydrophobic interactions. However, the binding reaction for the intact erythrocytes shows large negative values for both AH and AS. The values of K for the membranes and ΔH for the intact erythrocytes increased with the increase of the hydrophobic character of the substituent group at the C‐2 position of the phenothiazine nucleus (H < Cl < CF3). The results indicate that phenothiazines bind and/or penetrate to the inner membranes of the erythrocytes and react with intracellular components such as haemoglobin, while anti‐inflammatory drugs bind to the surface protein on the membranes with a lower affinity (K = 103 M−1) than phenothiazines, reflecting the small negative ΔH and positive ΔS for the interaction with intact erythrocytes. 1990 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:637 / 641
页数:5
相关论文
共 23 条
[1]   BIOTHERMODYNAMIC CHARACTERIZATION OF ERYTHROCYTE HEMOLYSIS INDUCED BY PHENOTHIAZINE-DERIVATIVES AND ANTI-INFLAMMATORY DRUGS [J].
AKI, H ;
YAMAMOTO, M .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (02) :396-398
[2]  
AKI H, 1989, J PHARM PHARMACOL, V41, P675
[3]   BINDING OF CHLORPROMAZINE AND IMIPRAMINE TO RED-CELLS, ALBUMIN, LIPOPROTEINS AND OTHER BLOOD COMPONENTS [J].
BICKEL, MH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (10) :733-738
[4]   INHIBITION OF ANION TRANSPORT IN THE RED-BLOOD-CELL BY ANIONIC AMPHIPHILIC COMPOUNDS .2. CHEMICAL-PROPERTIES OF THE FLUFENAMATE-BINDING SITE ON THE BAND-3 PROTEIN [J].
COUSIN, JL ;
MOTAIS, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 687 (02) :156-164
[5]   BINDING OF SALICYLATE AND SULFATHIAZOLE BY WHOLE-BLOOD CONSTITUENTS [J].
CRUZE, CA ;
MEYER, MC .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (01) :33-37
[6]   PREPARATION AND CHEMICAL CHARACTERISTICS OF HEMOGLOBIN-FREE GHOSTS OF HUMAN ERYTHROCYTES [J].
DODGE, JT ;
HANAHAN, DJ ;
MITCHELL, C .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1963, 100 (01) :119-&
[7]  
Exner O., 1973, PROG PHYS ORG CHEM, V10, P411
[8]   THE CORRELATION BETWEEN DRUG-BINDING TO THE HUMAN-ERYTHROCYTE AND ITS HEMOLYTIC-ACTIVITY [J].
HORIE, T ;
SUGIYAMA, Y ;
AWAZU, S ;
HANANO, M .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1981, 4 (02) :116-122
[9]  
KANAHO Y, 1981, MOL PHARMACOL, V20, P704
[10]   PHYSICOCHEMICAL ASPECTS OF DRUG-PROTEIN INTERACTIONS - GENERAL PERSPECTIVE [J].
KLOTZ, IM .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) :18-35